Cytomed therapeutics pte ltd
WebSep 21, 2024 · CytoMed Therapeutics Pte Ltd Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public … WebContact Number: +607-3824911. Email: [email protected]. IPSC Depository Sdn Bhd and IPSCBank Pte Ltd are subsidiaries of CytoMed Therapeutics Pte Ltd (CytoMed) which mainly focuses on the banking of our customers' cells such as PBMCs, iPSCs and MSCs for future usage. CytoMed Therapeutics is a deep tech company incorporated in …
Cytomed therapeutics pte ltd
Did you know?
WebThe company was formerly known as CytoMed Therapeutics Pte. Ltd. We conduct our business activities primarily through our direct wholly owned subsidiary in Malaysia, CytoMed Malaysia, but may be commencing more research and clinical trial activities in Singapore through CytoMed moving forward. ... CytoMed Therapeutics Limited: … WebOn January 19, 2024, the registrant converted from a private company limited by shares incorporated in Singapore, known as CytoMed Therapeutics Pte. Ltd. to a public …
WebCytoMed Therapeutics Pte. Ltd. (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed WebFeb 1, 2024 · By Colin Kellaher. CytoMed Therapeutics Pte. Ltd. on Wednesday said it plans to sell about 2.41 million shares at between $4 and $5 apiece in its initial public …
Web21 hours ago · CytoMed Therapeutics Pte. Ltd GDTC IPO will take place April, 14 on the NASDAQ exchange under the ticker GDTC. The company is offering shares at an expected price between $4.00 and $5.00 per share ... Web10 hours ago · SINGAPORE, April 14, 2024 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company"), a pre-clinical biopharmaceutical company …
WebOct 15, 2024 · Information on valuation, funding, cap tables, investors, and executives for CytoMed Therapeutics. Use the PitchBook Platform to explore the full profile.
WebCytoMed Therapeutics Pte Ltd 新细胞医学 298 Follower:innen auf LinkedIn Advancing Cancer Immunotherapy. Pioneering Stem Cell Research & Therapy. Patented Technology. In-house GMP facility. Incorporated in 2024, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research ( A*Star) and focuses on … aliberti torinoWebCytoMed Therapeutics Pte Ltd (registration no. 202408327H) a company incorporated in the Republic of Singapore and having its registered office at 21 Bukit Batok Crescent, #17-80 WCEGA Tower, Singapore 658065 (“CytoMed Singapore”) or its nominee(s); and aliberti zuccheroWebMar 30, 2024 · Addendum to License Agreement, dated December 1, 2024, by and among Accelerate Technologies Pte. Ltd. and CytoMed Therapeutics Pte. Ltd. 10.5#*** Second Addendum to License Agreement by way of a letter dated September 23, 2024, from CytoMed Therapeutics Pte. Ltd. and accepted by Accelerate Technologies Pte. Ltd. on … mnp 仕組み システムWeb10 hours ago · Apr 14, 2024. SINGAPORE, April 14, 2024 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company"), a pre-clinical biopharmaceutical company focused on harnessing its licensed ... aliberti scafatiWebApr 10, 2024 · CytoMed Therapeutics Limited was founded in 2013 and has 25 employees. The company is located at 1 Commonwealth Lane #08-22 Singapore 149544 and can be reached via phone at +65 6250 7738 or on... mnp 予約番号とはWebMar 9, 2024 · CYTOMED THERAPEUTICS PTE. LTD. (the "Company") is a Private Company Limited by Shares, incorporated on 9 March 2024 (Friday) in Singapore . The address of the Company's registered office is at the WCEGA TOWER building. The Company current operating status is live and has been operating for 1520589905. This … mnp 何時までWebCytoMed Therapeutics Pte. Ltd. operates as a pre-clinical biopharmaceutical company. The Company focuses on developing novel cell-based immunotherapies for treatment of … mnp 予約番号 解約 タイミング